Elena Formisano

•  

• Formisano E, Proietti E, Borgarelli C, Sukkar SG, Albertelli M, Boschetti M, Pisciotta L.
  The impact of overweight on lipid phenotype in different forms of dyslipidemia: a retrospective cohort study.
  J Endocrinol Invest. 2024 Apr 11
  • Pasta A, Pelizzaro F, Marabotto E, Calabrese F, Formisano E, Djahandideh Sheijani S, Brandimarte G, Manes G, Gravina AG, Savarino EV.
  Patient journey in gastroesophageal reflux disease: real-world perspectives from Italian gastroenterologists, primary care physicians, and ENT specialists.
  Therap Adv Gastroenterol. 2024 Mar 22;17:17562848241239590.
  • D'Erasmo L, Bini S, Casula M, Gazzotti M, Bertolini S, Calandra S, Tarugi P, Averna M, Iannuzzo G, Fortunato G, Catapano AL, Arca M; LIPIGEN HoFH group.
  Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry
  Eur J Prev Cardiol. 2024 Feb 20.
  • Pasta A, Formisano E, Calabrese F, Plaz Torres MC, Bodini G, Marabotto E, Pisciotta L, Giannini EG, Furnari M.
  Food Intolerances, Food Allergies and IBS: Lights and Shadows
  Nutrients. 2024 Jan 16;16(2):265.
  • Giannini EG, Testa T, Grillo F, Mastracci L, Arrigo S, Cai P, Paolino S, Burlando M, Pisciotta L, Formisano E, Cittadini G, Copello F, Tuo S, Bodini G.
  Institution of an interdisciplinary IBD centre is associated with improved healthcare utilisation
  Eur J Clin Invest. 2023 Dec 2:e14143. doi: 10.1111/eci.14143.
  • Formisano E, Schiavetti I, Gradaschi R, Gardella P, Romeo C, Pisciotta L, Sukkar SG.
  The Real-Life Use of a Protein-Sparing Modified Fast Diet by Nasogastric Tube (ProMoFasT) in Adults with Obesity: An Open-Label Randomized Controlled Trial
  Nutrients. 2023 Nov 17;15(22):4822
  • Cogorno L*, Formisano E*, Vignati A, Prigione A, Tramacere A, Borgarelli C, Sukkar SG, Pisciotta L.
  Non-alcoholic fatty liver disease: dietary and nutraceutical approaches
  Liver Research, Volume 7, Issue 3, 2023, Pages 216-227
  (*co-first authors)
  • Casula M, Gazzotti M, Capra ME, Olmastroni E, Galimberti F, Catapano AL, Pederiva C, the LIPIGEN Group and the LIPIGEN Paediatric Group.
  Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study
  Atherosclerosis. 2023 Nov; 385:117231.
  • Formisano E, Proietti E, Borgarelli C, Pisciotta L.
  Psoriasis and Vitamin D: A Systematic Review and Meta-Analysis
  Nutrients. 2023 Jul 30;15(15):3387.
  • Olmastroni, E., Gazzotti, M., Averna, M., Arca, M., Tarugi, P., Calandra, S., Bertolini, S., Catapano, A. L., Casula, M., & LIPIGEN Study Group
  Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial HypercholesterolemiaJournal of the American Heart Association, 12(10), e029223.

• • Pasta A, Borro P, Cremonini AL, Formisano E, et al. 

• Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single-center observational study
  Pharmacol Res Perspect. 2021 Oct;9(5):e00820
  • Caccialanza R, Cereda E, Klersy C, Nardi M, Masi S, Crotti S, Cappello S, Caissutti V, Brovia C, Lobascio F, Formisano E, et al. 
  The efficacy of immunonutrition in improving tolerance to chemoradiotherapy in patients with head and neck cancer, receiving nutritional counseling: study protocol of a randomized, open-label, parallel group, bicentric pilot study
  Ther Adv Med Oncol. 2021 Sep 11;13:17588359211025872.
  • Cremonini AL, Formisano E, Pasta A, Borgarelli C, Fresa R, Pisciotta L.
  Evaluation of the efficacy of plant sterols supplement sterolip® ESI in patients with type IIA hypercholesterolemia in relation to Genetic variants modulating intestinal absorption of cholesterol.
  J Food Sci Nutr Res 2021; 4 (3): 181-193
  • Caccialanza R, Formisano E, Klersy C, Ferretti V, Ferrari A, Demontis S et al.
  Nutritional parameters associated with prognosis in non-critically ill hospitalized COVID-19 patients: The NUTRI-COVID19 study.
  Clin Nutr. 2022 Dec;41(12):2980-2987.
  • Formisano E, Pasta A, Cremonini AL, Di Lorenzo I., Sukkar SG, Pisciotta L.
  Effects of a Mediterranean Diet, Dairy, and Meat Products on Different Phenotypes of Dyslipidemia: A Preliminary Retrospective Analysis.
  Nutrients. 2021 Apr 1;13(4):1161
  • Formisano E, Di Maio P, Ivaldi C, Sferrazzo E, et al. 
  Nutritional therapy for patients with coronavirus disease 2019 (COVID-19): Practical protocol from a single center highly affected by an outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
  Nutrition. 2021 Feb;82:111048
  • Pasta A, Cremonini AL, Formisano E, Fresa R, Bertolini S, Pisciotta L.
  Long term follow-up of genetically confirmed patients with familial hypercholesterolemia treated with first and second-generation statins and then with PCSK9 monoclonal antibodies.
  Atherosclerosis 2020 Jul 29;308:6-14
  • Pasta A*, Formisano E*, Cremonini AL, Maganza E, Parodi E, Piras S, Pisciotta L.
  Diet and Nutraceutical Supplementation in Dyslipidemic Patients: First Results of an Italian Single Center Real-World Retrospective Analysis
  Nutrients. 2020 Jul 10;12(7):2056
  (*co-first authors)
  • Formisano E, Pasta A, Cremonini AL et al.
  Efficacy of Nutraceutical Combination of Monacolin K, Berberine, and Silymarin on Lipid Profile and PCSK9 Plasma Level in a Cohort of Hypercholesterolemic Patients.
  J Med Food. 2020 Jun;23(6):658-666
   

• (ABSTRACT ONLY)
  • Bodini G, Pasta A, Formisano E, Calabrese F, Apollonio M, Pisciotta L, Giannini EG.
  P1066 The real-life use of the Crohn's disease exclusion diet (CDED) in adults with mild-to-moderate Crohn's disease activity: an interim analysis of an open-label randomized controlled trial
  Journal of Crohn's and Colitis, Volume 18, Issue Supplement_1, January 2024, Page i1915
  • Cremonini AL, Pasta A, Visconti L, Formisano E,et al .
  The levels of lipoprotein (A) in the modulation of carotid atherosclerosis risk in a group of patients with metabolic syndrome in primary prevention
  Atherosclerosis. 2020;315:e143.
  • Formisano E, Ivaldi C, Sferrazzo E, Arieta L, Bongiovanni S, Panizzi L, Demontis S.
  Nutritional management of non-critically ill hospitalized patients affected by Covid-19: The experience of dietitians in an Italian single center
  Clin Nutr ESPEN. 2020 Dec;40:609.
  • Cereda E, Formisano E, Klersy C et al. 
  Nutritional parameters associated with prognosis in non-critically ill hospitalized covid-19 patients: the nutri-covid19 study
  Clin Nutr ESPEN. 2021 Dec;46:S547
  • Formisano E, Pasta A, Cremonini AL, Di Lorenzo I, Pisciotta L.
  Evaluation of adherence to Mediterranean diet, assessed by a food frequency questionnaire, in dyslipidemic patients and evaluation of dietary intervention efficacy
  Atherosclerosis. 2020;315:e219-e220.
  • Formisano E, Pasta A, Cremonini AL, Garrubba C, Borro P, Picciotto A, Pisciotta L.
  Role of dietary intervention in patients with metabolic syndrome and NAFLD-NASH.
  Atherosclerosis. 2020;315:e262.
  • Pasta A, Cremonini AL, Formisano E, Fresa R, Bertolini S, Pisciotta L.
  Long-term follow-up of genetically confirmed patients with familial hypercholesterolemia from the treatment with the first-generation statins to monoclonal anti-PCSK9 antibodies
  Atherosclerosis. 2020;315:e212

​

• PUBBLICAZIONI SU RIVISTE NAZIONALI
  • Formisano E, Proietti E, Pisciotta L.
  MAFLD: terapia dietetica e supplementi nutraceutici
  Giornale Italiano dell’Arteriosclerosi 2023; 14 (2): 42-56
  • Formisano E, Proietti E, Bertolini A, Spandonari Barreto V, Pisciotta L.
  Aspetti dietetici e farmacologici nelle dislipidemie
  Cardiologia Ambulatoriale 2023, 1: 39-53

​

     LIBRI

      MANUALE DI DIETISTICA E DIETETICA APPLICATA VOLUME 1 e 2

• Borgarelli C, Bruzzone F, Pisciotta L. e con i contributi di Formisano E, Giovene Buller L, Ierardi M, Proietti L.t ab edizioni – 2023